CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
64.59
-2.38 (-3.55%)
May 12, 2025, 3:50 PM - Market open
CVS Health Revenue
CVS Health had revenue of $94.07B in the quarter ending March 31, 2025, with 6.92% growth. This brings the company's revenue in the last twelve months to $376.74B, up 4.75% year-over-year. In the year 2024, CVS Health had annual revenue of $370.66B with 3.93% growth.
Revenue (ttm)
$376.74B
Revenue Growth
+4.75%
P/S Ratio
0.22
Revenue / Employee
n/a
Employees
n/a
Market Cap
81.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 370.66B | 14.03B | 3.93% |
| Dec 31, 2023 | 356.62B | 34.99B | 10.88% |
| Dec 31, 2022 | 321.63B | 30.72B | 10.56% |
| Dec 31, 2021 | 290.91B | 23.00B | 8.59% |
| Dec 31, 2020 | 267.91B | 12.14B | 4.75% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
CVS News
- 1 hour ago - CVS Health celebrates reopening of Hendersonville store destroyed by Hurricane Helene - PRNewsWire
- 19 hours ago - CVS Health: Big 2025 Momentum, Strong Growth Ahead, Shares Underpriced - Seeking Alpha
- 1 day ago - CVS Health: Firing On All Cylinders, Thanks To The Promising Reversal - Seeking Alpha
- 1 day ago - 3 Ideal Buys From 63 May Fortune 500 Industry Leaders - Seeking Alpha
- 4 days ago - CVS Backs Health-Tech Firm Kouper's $10 Million Fundraise - PYMNTS
- 5 days ago - Healthy Returns: Novo Nordisk's Wegovy deal with CVS won't derail Eli Lilly's obesity market dominance - CNBC
- 5 days ago - Build A 12%+ Yield On Cost By 2035 With May's Top 10 High-Yield Picks - Seeking Alpha
- 5 days ago - Activist investor Glenview Capital reduces stake in CVS Health - Reuters